Stevanato Group S.p.A (STVN) Operating Expenses (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Operating Expenses of $36.4 million for Q1 2026, up 13.84% year-over-year from $32.0 million in Q1 2025, and down 3.48% quarter-over-quarter from $37.7 million in Q4 2025.
Stevanato Group S.p.A (STVN) Operating Expenses (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Operating Expenses for 7 consecutive years, with $36.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 13.84% year-over-year to $36.4 million; the TTM figure through Mar 2026 stood at $145.7 million (up 9.96% YoY), while the FY2025 annual figure was $145.6 million, up 8.67% from the prior year.
- Operating Expenses eased to $36.4 million in Q1 2026 per STVN's latest filing, from $37.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $37.7 million in Q4 2025 and bottomed at $27.8 million in Q3 2022.
- Historically, Operating Expenses has averaged $33.8 million across 5 years, with a median of $34.1 million in 2023.
- On a YoY basis, Operating Expenses climbed as much as 111.89% in 2022 and fell as far as 26.59% in 2022.
- Stevanato Group S.p.A's Operating Expenses stood at $36.2 million in 2022, then rose by 0.11% to $36.3 million in 2023, then declined by 8.64% to $33.1 million in 2024, then advanced by 13.85% to $37.7 million in 2025, then retreated by 3.48% to $36.4 million in 2026.
- Business Quant data shows STVN's Operating Expenses at $36.4 million in Q1 2026, $37.7 million in Q4 2025, and $36.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.72 Bn | 128.51 Bn | 1.96 Bn | 988.50 Mn |
| 2 | Becton Dickinson | 52.22 Bn | 51.35 Bn | 2.32 Bn | 4.32 Bn |
| 3 | Alcon | 35.68 Bn | 34.32 Bn | 1.68 Bn | 1.63 Bn |
| 4 | Resmed | 33.70 Bn | 32.23 Bn | 861.22 Mn | 412.51 Mn |
| 5 | Medline | 28.68 Bn | 26.01 Bn | 2.22 Bn | 1.82 Bn |
| 6 | West Pharmaceutical Services | 24.95 Bn | 24.51 Bn | 329.20 Mn | 137.30 Mn |
| 7 | Solventum | 15.35 Bn | 14.95 Bn | 1.29 Bn | 1.11 Bn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 718.70 Mn |
| 9 | Baxter International | 13.53 Bn | 11.38 Bn | 1.03 Bn | 864.00 Mn |
| 10 | Stevanato Group S.p.A | 6.13 Bn | 6.02 Bn | 100.91 Mn | 34.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.66 Mn |
| Mar 31, 2026 | 36.40 Mn |
| Dec 31, 2025 | 37.72 Mn |
| Sep 30, 2025 | 36.71 Mn |
| Jun 30, 2025 | 34.87 Mn |
| Mar 31, 2025 | 31.98 Mn |
| Dec 31, 2024 | 33.13 Mn |
| Sep 30, 2024 | 31.74 Mn |
| Jun 30, 2024 | 35.65 Mn |
| Mar 31, 2024 | 35.26 Mn |
| Dec 31, 2023 | 36.26 Mn |
| Sep 30, 2023 | 31.46 Mn |
| Jun 30, 2023 | 34.07 Mn |
| Mar 31, 2023 | 33.06 Mn |
| Dec 31, 2022 | 36.22 Mn |
| Sep 30, 2022 | 27.76 Mn |
| Jun 30, 2022 | 32.91 Mn |
| Mar 31, 2022 | 29.40 Mn |
| Dec 31, 2021 | 31.23 Mn |
| Sep 30, 2021 | 37.81 Mn |